99% Savings - Buy Just @1 Rs X
Imicrit 500/500 Mg Injection is a prescription medicine that is available as a Injection. Secondary and off-label uses of Imicrit 500/500 Mg Injection have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Imicrit 500/500 Mg Injection. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Imicrit 500/500 Mg Injection as well, which are listed below. These side effects of Imicrit 500/500 Mg Injection are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Imicrit 500/500 Mg Injection's effect is Moderate during pregnancy and Moderate for lactating mothers. In addition, Imicrit 500/500 Mg Injection's effects on the liver, heart and kidney are discussed below in the Imicrit 500/500 Mg Injection related warnings section.
Imicrit 500/500 Mg Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Imicrit 500/500 Mg Injection in conditions like Kidney Disease, Kidney Disease. Some other conditions that can be affected by Imicrit 500/500 Mg Injection are listed in the contraindications section below.
Besides this, Imicrit 500/500 Mg Injection may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Imicrit 500/500 Mg Injection is safe while driving, and is is addictive in nature.
Imicrit 500/500 Mg Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Imicrit 500/500 Mg Injection safe for pregnant women?
Imicrit may have some side effects during pregnancy. Pregnant women should discontinue the use of Imicrit, and talk to their doctor, if they notice any discomfort.
Is the use of Imicrit 500/500 Mg Injection safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Imicrit. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Imicrit 500/500 Mg Injection on the Kidneys?
There can be some harmful effects on your kidneys after taking Imicrit. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Imicrit 500/500 Mg Injection on the Liver?
Imicrit can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Imicrit 500/500 Mg Injection on the Heart?
Side effects of Imicrit rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Imicrit 500/500 Mg Injection unless your doctor advises you to do so -
Is this Imicrit 500/500 Mg Injection habit forming or addictive?
Imicrit 500/500 Mg Injection does not cause addiction.
Interaction between Food and Imicrit 500/500 Mg Injection
Taking Imicrit 500/500 Mg Injection with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Imicrit 500/500 Mg Injection
Consumption of alcohol and Imicrit 500/500 Mg Injection together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Primaxin® (imipenem and cilastatin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 731
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 676-678